Pearl River Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,814
| Closed | -$3.14M | – | 599 |
|
|
2023
Q3 | $3.14M | Sell |
3,814
-3,019
| -44% | -$2.48M | 0.49% | 50 |
|
|
2023
Q2 | $4.91M | Buy |
6,833
+3,960
| +138% | +$2.85M | 0.79% | 17 |
|
|
2023
Q1 | $2.36M | Sell |
2,873
-46
| -2% | -$37.8K | 0.37% | 76 |
|
|
2022
Q4 | $2.11M | Sell |
2,919
-724
| -20% | -$522K | 0.36% | 80 |
|
|
2022
Q3 | $2.51M | Sell |
3,643
-1,715
| -32% | -$1.18M | 0.47% | 53 |
|
|
2022
Q2 | $3.17M | Buy |
+5,358
| New | +$3.17M | 0.74% | 24 |
|
|
2022
Q1 | – | Sell |
-3,420
| Closed | -$2.16M | – | 535 |
|
|
2021
Q4 | $2.16M | Buy |
+3,420
| New | +$2.16M | 0.58% | 39 |
|
|
2021
Q2 | – | Sell |
-4,548
| Closed | -$2.15M | – | 548 |
|
|
2021
Q1 | $2.15M | Buy |
4,548
+1,112
| +32% | +$526K | 0.69% | 35 |
|
|
2020
Q4 | $1.66M | Buy |
+3,436
| New | +$1.66M | 0.59% | 36 |
|
|
2020
Q2 | – | Sell |
-156
| Closed | -$76K | – | 522 |
|
|
2020
Q1 | $76K | Buy |
+156
| New | +$76K | 0.15% | 188 |
|
|
2019
Q3 | – | Sell |
-312
| Closed | -$98K | – | 503 |
|
|
2019
Q2 | $98K | Buy |
+312
| New | +$98K | 0.63% | 75 |
|